Ken Griffin Hutchmed (China) LTD Put Options Transaction History
Citadel Advisors LLC
- $509 Billion
- Q1 2025
Put Options
10 transactions
Others Institutions Holding HCM
# of Institutions
62Shares Held
6.43MCall Options Held
9.9KPut Options Held
9.6K-
Schroder Investment Management Group London, X02.84MShares$46.3 Million0.05% of portfolio
-
Allianz Asset Management Gmb H Munich, 2M1MShares$16.4 Million0.02% of portfolio
-
State Street Corp Boston, MA337KShares$5.49 Million0.0% of portfolio
-
Aia Group LTD Hong Kong, K3315KShares$5.14 Million0.13% of portfolio
-
M&G PLC London, X0259KShares$4.22 Million0.03% of portfolio
About HUTCHMED (China) Ltd
- Ticker HCM
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 172,955,008
- Market Cap $2.82B
- Description
- HUTCHMED (China) Limited discovers, develops, and commercializes targeted therapeutics and immunotherapies for cancer and immunological diseases in HongKong and internationally. It operates in Oncology/Immunology and Other Ventures segments. The company develops Savolitinib, an inhibitor for non-small cell lung cancer (NSCLC), papillary and rena...